<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/84EC36D9-AAC8-496A-B69B-F9DE2213B154"><gtr:id>84EC36D9-AAC8-496A-B69B-F9DE2213B154</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/17C09846-1EBC-4F8C-BD3E-1E7E0B2D4F3A"><gtr:id>17C09846-1EBC-4F8C-BD3E-1E7E0B2D4F3A</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>O'Brien</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FE02002X%2F1"><gtr:id>F7DED0E5-1CDC-4DB7-8D32-D4E7125926D5</gtr:id><gtr:title>Back to Basics: Investigating Structure, Reactivity and Catalysis of Organolithium-Diamine Complexes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/E02002X/1</gtr:grantReference><gtr:abstractText>This project is concerned with developing a deeper insight into a fundamental process in organic chemistry, namely deprotonation of a weak carbon acid using a strong base. Acid-base interactions and deprotonation is a concept first met in school chemistry classes (acid-base titrations). Deprotonation using a strong base composed of a reactive organolithium reagent complexed to a diamine has become one of the most powerful tools in organic synthesis in recent times. It is also possible to use a chiral diamine (of which naturally occurring (/)-sparteine is the most famous) to control the stereochemistry (or handedness) of the products. Unfortunately, despite their widespread use in synthesis, very little structural and mechanistic information is known about these organolithium-diamine complexes. In this project, collaboration between two groups (O'Brien, York, UK) and (Hilmersson, Goteborg, Sweden) with complementary areas of expertise will be established to unravel the complexities of organolithium-diamine-mediated deprotonation processes. The research will investigate the kinetics and thermodynamics of complexing diamines to organolithiums as well as the solution structures and stoichiometry of the complexes that are formed. This project will also deliver a considerable body of kinetic data on reactivity of organolithiums complexed to diamines which will inform the synthetic chemists and allow organolithium reactions to be optimised (in industry and academia). All of these results will be combined to understand and rationalise one-ligand and two-ligand catalytic asymmetric deprotonation processes, an under-developed research area, which has received no mechanistic attention thus far. This project is of much importance and use to Process R &amp;amp; D groups of, for example, pharmaceutical companies and Astra-Zeneca are specifically supporting the research.</gtr:abstractText><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>109664</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>22800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>38DF73A4-858E-4F73-86CD-1D349CCE188C</gtr:id><gtr:outcomeId>5ec4999e5ec499b2</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AstraZeneca</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>BB1AEBD7-09B3-463C-B666-36A1AC31CFE3</gtr:id><gtr:outcomeId>5ec1b7425ec1b760</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This project focused on the area of synthetic organic chemistry. In particular, some fundamental studies on the reactions of strong organolithium bases were explored. Two key findings were: (i) a new type of reactivity of an organolitihum diamine complex and (ii) the ability to functionalise piperidines. Piperidines are common features in pharmaceuticals and this advance could be very useful for the synthesis of the drugs of the future.</gtr:description><gtr:exploitationPathways>Methodology may be used in the pharmaceutical industry for the synthesis of drug molecules.</gtr:exploitationPathways><gtr:id>A5E338F9-5F67-4D3E-A3A5-C70A66A222E4</gtr:id><gtr:outcomeId>546205506acdf7.71885541</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5732DA76-88A8-4749-A5F4-9F56A7354CE0</gtr:id><gtr:title>Asymmetric deprotonation of N-boc piperidine: react IR monitoring and mechanistic aspects.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af64aef6dc1ceb5df80278338c1f7724"><gtr:id>af64aef6dc1ceb5df80278338c1f7724</gtr:id><gtr:otherNames>Stead D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d01701740b3d34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF0C45D-67AB-4C92-933A-E5872BA57F30</gtr:id><gtr:title>Asymmetric synthesis via aziridinium ions: exploring the stereospecificity of the ring opening of aziridinium ions and a formal synthesis of (-)-swainsonine</gtr:title><gtr:parentPublicationTitle>Tetrahedron: Asymmetry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff3de957fe0adb978ec6f3a8ad3b1b45"><gtr:id>ff3de957fe0adb978ec6f3a8ad3b1b45</gtr:id><gtr:otherNames>Oxenford S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>m_2749386701139706b8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C92E201-AC68-4623-A43A-1E612A1D46E9</gtr:id><gtr:title>Amines bearing tertiary substituents by tandem enantioselective carbolithiation-rearrangement of vinylureas.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87d0a26c8ad740e63a7f7599d7c0cec0"><gtr:id>87d0a26c8ad740e63a7f7599d7c0cec0</gtr:id><gtr:otherNames>Tait M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5461e3d80ee3c8.92548493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDC98A4E-2E1B-4ED0-A106-DD613A065875</gtr:id><gtr:title>Asymmetric deprotonation using s-BuLi or i-PrLi and chiral diamines in THF: the diamine matters.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81ea9a2e566f65b254e50a45d5e6e328"><gtr:id>81ea9a2e566f65b254e50a45d5e6e328</gtr:id><gtr:otherNames>Carbone G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d0170175683908</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/E02002X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>64596636-AE88-4F6E-A816-9C4C203E1197</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Catalysis &amp; surfaces</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>666CC8F4-4525-49AF-91C1-5675E0C8ADDF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chem. React. Dyn. &amp; mechanisms</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>41B6965D-D659-4099-9434-7C61B7E5BEF2</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Asymmetric Chemistry</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>35E9CECD-F211-4914-9F91-4B8FB76B773D</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Catalysis &amp; Applied Catalysis</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>008D950C-182A-427B-A7CB-4FD430D040B5</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Physical Organic Chemistry</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>